Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SDN-037 for inflammation and pain after ocular surgery
NCT03426267Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Sep 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SDN-037 in ocular inflammation, sponsored by Sun Pharma. Started Sep 2018; status: completed.
02
Drugs
SDN-037
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT03426267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03426267.